masokista meaning

masokista meaning

Daltonganj: Ayushman card creation for 31 inmates of Daltonganj Central Jail remained disrupted for the third day on Tuesday due to server outage . Ayushman Mitra Ranjan Singh said, “The issue has been continuing since Sunday. No card could be made even Tuesday.” tnn We also published the following articles recently Technical glitch halts Ayushman Bharat camp at Daltonganj central jail The inaugural Ayushman Bharat registration camp at Daltonganj Central Jail faced technical glitches, disappointing inmates and their families. Despite efforts by officials, server issues halted the registration process. Judge Srivastav plans to reschedule the camp once server problems are resolved. Additionally, an Aadhaar rectification camp is planned to address documentation discrepancies among inmates. Server outage dogs Ayushman card generation for 3rd day Server outages have disrupted the creation of Ayushman cards for 31 prisoners at Daltonganj Central Jail for three days. Ayushman Mitra Ranjan Singh reported no cards could be prepared due to ongoing issues. Principal district and sessions judge Niraj Kumar Srivastav expressed concern and plans to contact health and home department officials if issues persist. Six sent to police remand in Ayushman Bharat health card scam A local court in Ahmedabad has sent six individuals to three-day police custody in connection with a scam involving the fabrication of health cards under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana. The investigation began after the deaths of two beneficiaries at Khyati Hospital. Police seek further custodial interrogation to explore additional details and potential involvement of others. Stay updated with the latest news on Times of India . Don't miss daily games like Crossword , Sudoku , Location Guesser and Mini Crossword . Spread love this holiday season with these Christmas wishes , messages , and quotes .JAMES MADISON 71, JACKSONVILLE STATE 65

Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30%, according to a study. Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low dose, but a new clinical trial has found that a higher single dose can be very effective if injected at the time of a flare-up. The findings, published in the Lancet Respiratory Medicine, included 158 people who needed medical attention in A&E for their asthma or COPD attack (COPD is a group of lung conditions that cause breathing difficulties). Patients were given a quick blood test to see what type of attack they were having, with those suffering an “eosinophilic exacerbation” involving eosinophils (a type of white blood cell) being suitable for treatment. Around 50% of asthma attacks are eosinophilic exacerbations, as are 30% of COPD ones, according to the scientists. The clinical trial, led by King’s College London and carried out at Oxford University Hospitals NHS Foundation Trust and Guy’s and St Thomas’ NHS Foundation Trust, saw patients randomly split into three groups. One group received the benralizumab injection and dummy tablets, another received standard care (prednisolone steroids 30mg daily for five days) and a dummy injection, and the third group received both the benralizumab injection and steroids. After 28 days, respiratory symptoms of cough, wheeze, breathlessness and sputum were found to be better in people on benralizumab. And after 90 days, there were four times fewer people in the benralizumab group who failed treatment compared with those receiving steroids. Treatment with the benralizumab injection also took longer to fail, meaning fewer visits to a GP or hospital for patients, researchers said. Furthermore, people also reported a better quality of life on the new regime. Scientists at King’s said steroids can have severe side-effects such as increasing the risk of diabetes and osteoporosis, meaning switching to benralizumab could provide huge benefits. Lead investigator Professor Mona Bafadhel, from King’s, said: “This could be a game-changer for people with asthma and COPD. “Treatment for asthma and COPD exacerbations have not changed in 50 years, despite causing 3.8 million deaths worldwide a year combined. “Benralizumab is a safe and effective drug already used to manage severe asthma. “We’ve used the drug in a different way – at the point of an exacerbation – to show that it’s more effective than steroid tablets, which is the only treatment currently available.” Researchers said benralizumab could also potentially be administered safely at home or in a GP practice, as well as in A&E. First author Dr Sanjay Ramakrishnan, clinical senior lecturer at the University of Western Australia, said: “Our study shows massive promise for asthma and COPD treatment. “COPD is the third leading cause of death worldwide but treatment for the condition is stuck in the 20th century. “We need to provide these patients with life-saving options before their time runs out.” Dr Samantha Walker, director of research and innovation at Asthma and Lung UK, welcomed the findings but said: “It’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is.” AstraZeneca provided the drug for the study and funded the research, but had no input into trial design, delivery, analysis or interpretation.

Are international thieves exploiting tourist visas to target pro-athletes' homes?

First Quarter NMSU_Early 30 interception return (Montano kick), 12:46. NMSU_FG Montano 42, 2:22. Second Quarter MTU_Credle 3 run (Rankin kick), 10:56. NMSU_FG Montano 26, 1:35. Third Quarter NMSU_McGowan 12 pass from Nunez (Montano kick), 9:55. MTU_Willis 12 pass from Vattiato (Rankin kick), 3:56. NMSU_Washington 11 run (run failed), 1:22. Fourth Quarter MTU_Kelly 19 pass from Vattiato (Rankin kick), 12:41. NMSU_Sheehan 4 pass from Nunez (Montano kick), 7:43. NMSU_FG Montano 21, 1:55. INDIVIDUAL STATISTICS RUSHING_New Mexico St., McGowan 12-83, Awad 9-22, Washington 12-22, McMillan 1-13, Johnson 1-5, Nunez 1-0. Middle Tennessee, Middlebrook 10-80, Wilkins 6-47, Credle 7-27, Vattiato 5-16. PASSING_New Mexico St., Awad 12-16-0-221, Nunez 2-2-0-16. Middle Tennessee, Vattiato 30-45-2-277. RECEIVING_New Mexico St., McGowan 6-96, Pride 4-51, David 1-38, Parks 1-38, Rudison 1-10, Sheehan 1-4. Middle Tennessee, Kelly 5-58, Middlebrook 5-29, M.Butler 4-31, Willis 3-67, Lacy 3-19, Sutton 2-18, Poticher 2-13, Carter 2-12, Credle 2-9, Sherman 1-15, Wilkins 1-6. MISSED FIELD GOALS_None.JUST IN: Fire Guts LAUTECH Teaching HospitalA police constable has allegedly been stabbed while trying to stop a group of men . or signup to continue reading The constable is recovering in hospital, where he is reported to be in a stable condition, and police have arrested three men and charged the alleged attacker. Police went to at 12.30am on November 22 after receiving reports that five men were seen fighting. A hatchback was spotted driving away as police arrived and officers called in support from aviation command to follow the car, police said. Police allege four of the men were in the hatchback and a fifth left the area on foot. The pursuit ended quickly, after the hatchback hit a power pole, and four men allegedly ran from the car. The 34-year-old constable was trying to arrest a 20-year-old man when he was stabbed in the chest, police said. The 20-year-old was charged with wounding a police officer executing duty (reckless as to actual bodily harm), wounding person with intent to cause grievous bodily harm, using an offensive weapon to prevent lawful detention, custody of a knife in a public place and assaulting a police officer in execution of duty without actual bodily harm. He was refused bail to appear in Blacktown Local Court on November 22. An 18-year-old and 21-year-old were also arrested and a crime scene has been established as the investigation continues. Police are searching for two other men spotted at the fight on Hill End Road. Anna Houlahan reports on crime and social issues affecting regional and remote Australia in her role as national crime reporter at Australian Community Media (ACM). She was ACM’s Trainee of the Year in 2023 and, aside from reporting on crime, has travelled the country as a journalist for Explore Travel Magazine. Reach out with news or updates to anna.houlahan@austcommunitymedia.com.au Anna Houlahan reports on crime and social issues affecting regional and remote Australia in her role as national crime reporter at Australian Community Media (ACM). She was ACM’s Trainee of the Year in 2023 and, aside from reporting on crime, has travelled the country as a journalist for Explore Travel Magazine. Reach out with news or updates to anna.houlahan@austcommunitymedia.com.au DAILY Today's top stories curated by our news team. WEEKDAYS Grab a quick bite of today's latest news from around the region and the nation. WEEKLY The latest news, results & expert analysis. WEEKDAYS Catch up on the news of the day and unwind with great reading for your evening. WEEKLY Get the editor's insights: what's happening & why it matters. WEEKLY Love footy? We've got all the action covered. WEEKLY Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. WEEKLY Going out or staying in? Find out what's on. WEEKDAYS Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. TWICE WEEKLY Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. WEEKLY Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. TWICE WEEKLY Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. AS IT HAPPENS Be the first to know when news breaks. DAILY Your digital replica of Today's Paper. Ready to read from 5am! DAILY Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Advertisement Advertisement